Hospital News and Research

RSS

Is 'model health system' Geisinger replicable elsewhere?

Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.

19 Oct 2009

CSC's HealthSpace Advisor selected by GHHS to optimize revenue generation

CSC today announced that the Georgia Hospital Health Services (GHHS), a subsidiary of the Georgia Hospital Association (GHA), has selected CSC's HealthSpace Advisor, a Web-based benchmarking tool introduced earlier this year, to help member hospitals analyze how effectively they use space in key revenue generating areas.

19 Oct 2009

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

A hospital that is using RapidArc radiotherapy to treat cancers of the head & neck and cervix is announcing it will be expanding its use for treatment of other cancers. Yashoda Cancer Institute in Hyderabad has found it can deliver image-guided, intensity modulated radiotherapy (IMRT) faster and more precisely using the RapidArc technology from Varian Medical Systems.

19 Oct 2009

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Applications (BLA) for Prolia(TM) (denosumab) in the treatment and prevention of postmenopausal osteoporosis.

19 Oct 2009

Clearcount Medical Solutions raises $3.4 million

ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today the close of its $3.4M Series B financing round. The company plans to use the funds to drive sales and product development of its RFID-based solutions designed to prevent retained surgical sponges.

19 Oct 2009

PLC Systems' RenalGuard to be utilized in a live case transmission at the GISE 2009 conference

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that its RenalGuard System(TM) will be utilized as part of a live case transmission from the Clinica Mediterranea, Naples, Italy, to the 30th Congresso Nazionale della Societa' Italiana di Cardiologia Invasiva (GISE) during the conference.

19 Oct 2009

The Beryl Companies in Inc. 5000 list of the fastest-growing private companies

The Beryl Companies, the nation's leading provider of outsourced call center services to healthcare organizations, has achieved a growth rate of 41 percent in the last three years, earning it a place in the prestigious Inc. 5000 list of the fastest-growing private companies in the country for the third straight year.

19 Oct 2009

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Alcohol and drug use are known contributors to adolescents engaging in dangerous sexual activity; leading to substantial health risks such as unwanted pregnancies, sexually transmitted illnesses, drug overdoses and alcohol poisonings. Yet, research suggests that fewer than half of pediatricians report screening patients for substance use and at-risk sexual behavior.

19 Oct 2009

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.

19 Oct 2009

Chinese SFDA approves China Medical Technologies' SPR System

China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its SPR- based analysis system (the "SPR System") from the State Food and Drug Administration of China (the "SFDA").

19 Oct 2009

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

Premier Plastic Surgery of Kansas City, serving residents of Kansas City and beyond for 22 years, has redesigned its extensive website to include a separate section on Cosmetic Surgery for Males, a new Skin Care Centre, and a Plastic Surgery Blog that features breaking news on emerging research, techniques and products.

19 Oct 2009

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.

19 Oct 2009

First Edition: October 19, 2009

Five Rivers Medical Center in Pocahontas, Ark., needs help to get a highly coveted "critical access" hospital designation - and the extra Medicare funding that comes with it. Sen. Mark Pryor, an Arkansas Democrat, intends to provide it.

19 Oct 2009

New decision-making tool offers breast reconstruction options post cancer surgery

A computer-based decision-making aid may make it possible for more women to have breast reconstruction after surgical treatment for cancer.

19 Oct 2009

IAVI and Ragon Institute sign MOU to devise new vaccine strategies for AIDS

The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development of new and promising AIDS vaccine candidates for testing.

19 Oct 2009

QLT receives exclusive U.S. sales and marketing rights for Visudyne therapy

QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.

19 Oct 2009

$Online education programs for medical professionals at a fraction of the cost of travel-based programs$

Online education programs for medical professionals at a fraction of the cost of travel-based programs

With business travel budgets expected to remain tight through 2010, online clinical best practice programs may offer the healthcare industry its best educational value, according to Sara McMannus, Program Manager of GE Healthcare’s Global Clinical Best Practice Education. “Vendor-neutral, online programs provide education on-demand at a fraction of the cost of travel-based programs,” she said.

19 Oct 2009

Lubricin injections can reduce cartilage degeneration

Medical researchers will report findings today (Oct. 19) that demonstrate that injecting the protein lubricin into knee joints can dramatically reduce cartilage degeneration.

19 Oct 2009

New mathematical model for rapid and accurate diagnoses of AHF

Researchers at St. Michael's Hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (AHF) in emergency room patients

19 Oct 2009

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

19 Oct 2009

Hospital News and Research

Is 'model health system' Geisinger replicable elsewhere?

CSC's HealthSpace Advisor selected by GHHS to optimize revenue generation

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Clearcount Medical Solutions raises $3.4 million

PLC Systems' RenalGuard to be utilized in a live case transmission at the GISE 2009 conference

The Beryl Companies in Inc. 5000 list of the fastest-growing private companies

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

Chinese SFDA approves China Medical Technologies' SPR System

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

First Edition: October 19, 2009

New decision-making tool offers breast reconstruction options post cancer surgery

IAVI and Ragon Institute sign MOU to devise new vaccine strategies for AIDS

QLT receives exclusive U.S. sales and marketing rights for Visudyne therapy

Online education programs for medical professionals at a fraction of the cost of travel-based programs

Lubricin injections can reduce cartilage degeneration

New mathematical model for rapid and accurate diagnoses of AHF

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News